Ignite Creation Date:
2025-12-24 @ 10:14 PM
Ignite Modification Date:
2026-02-26 @ 11:08 AM
Study NCT ID:
NCT05381935
Status:
WITHDRAWN
Last Update Posted:
2023-01-31
First Post:
2022-05-11
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of ES014 (Anti-CD39/TGF-β Bispecific Antibody) in Patients With Locally Advanced or Metastatic Solid Tumors
Sponsor:
Elpiscience Biopharma, Ltd.